Decoy Therapeutics Inc.
DCOY
Positions held
Your positionsDCOY isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $995,881 | Enterprise value | -$7.29M | Trailing P/E | 0.12 | Forward P/E | -0.18 |
| PEG | — | Price / book | 0.19 | Beta | 0.64 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | -10.6% |
| Profit margin | 0.0% | ROE | -8.3% | ROA | -73.3% | Debt / equity | — |
| Current ratio | 1.83 | Free cash flow | -$509,881 | Analyst recommendation | strong_buy | Mean target | $3.00 |
| 52w high | $55.92 | 52w low | $1.48 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$2.4M | -$2.2M | -$9.0M | -$0.9M | -$1.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$2.4M | -$2.3M | -$9.0M | -$0.9M | -$1.0M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$12.5M | -$5.6M | -$12.5M | -$31.6M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$12.6M | -$5.7M | -$12.9M | -$23.0M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today
2026-09-30 · Decoy Therapeutics to Present at The Small Cap Showcase
2026-09-29 · Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program
2026-09-22 · Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
2026-09-22 · /C O R R E C T I O N -- Decoy Therapeutics, Inc/
2026-09-22 · Decoy Therapeutics Enters Warrant Inducement Deal for $3.85 Million; Shares Rise
2026-09-22 · BC-Most Active Stocks
2026-09-22 · Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
2026-09-08 · Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
2026-08-12 · Decoy Therapeutics: Q2 Earnings Snapshot
Price (daily)
Full chart · RSI · MACD · patterns